期刊
DIABETES RESEARCH AND CLINICAL PRACTICE
卷 98, 期 2, 页码 E9-E11出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.diabres.2012.09.020
关键词
Angiogenesis; Diabetic retinopathy; Promyelocytic leukemia protein; Tumor suppressor; Vascular endothelial growth factor
资金
- Ministry of Education, Culture, Sports, Science and Technology of Japan
- Takeda Science Foundation
- Funding Program for Next Generation World-Leading Researchers (NEXT Program)
- Grants-in-Aid for Scientific Research [23890254] Funding Source: KAKEN
Aims: To examine the expression of promyelocytic leukemia protein (PML) in the eye of proliferative diabetic retinopathy (PDR) patients. Methods: PML mRNA levels were measured in proliferative membranes from 12 PDR patients and idiopathic epiretinal membranes from 5 control patients by quantitative RT-PCR. Protein levels of PML and vascular endothelial growth factor (VEGF) in aqueous humor and vitreous fluid samples from 34 PDR patients and 38 control patients were determined using ELISA. Results: The PML mRNA expression levels in membrane samples, and the PML protein concentrations in aqueous humor and vitreous fluid samples were significantly lower in PDR patients than control patients. We observed a statistically significant inverse correlation between the concentrations of PML and VEGF in the aqueous humor and vitreous fluid of PDR patients. Conclusion: PML may be a good candidate as a diagnostic marker and a therapeutic agent for PDR. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据